Clinical Trials Logo

Liver Neoplasms clinical trials

View clinical trials related to Liver Neoplasms.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02960620 No longer available - Clinical trials for HepatoCellular Carcinoma

Therasphere for Unresectable Primary or Secondary Liver Neoplasia

Start date: n/a
Phase:
Study type: Expanded Access

This is not a research study. The purpose is to provide supervised access to TheraSphere® therapy at this institution.

NCT ID: NCT01728051 No longer available - Cutaneous Melanoma Clinical Trials

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Start date: n/a
Phase: N/A
Study type: Expanded Access

The safety and efficacy of CS-PHP-melphalan has been evaluated in a phase 3 trial conducted in the same patient population as well as using the same melphalan dosing as proposed in this study. This expanded access protocol will provide an experimental alternative treatment option for both physicians and patients until the Delcath CS-PHP System receives marketing approval.

NCT ID: NCT00589030 No longer available - Liver Cancer Clinical Trials

Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Start date: April 2007
Phase: N/A
Study type: Expanded Access

RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: To provide expanded access and study the side effects of yttrium Y 90 glass microspheres in treating patients with liver cancer that cannot be removed by surgery.